Radiofrequency ablation of lung tumours
Open Access
- 20 July 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Insights into Imaging
- Vol. 2 (5), 567-576
- https://doi.org/10.1007/s13244-011-0110-7
Abstract
Pulmonary radiofrequency ablation (RFA) has become an increasingly adopted treatment option for primary and metastatic lung tumours. It is mainly performed in patients with unresectable or medically inoperable lung neoplasms. The immediate technical success rate is over 95%, with a low periprocedural mortality rate and 8–12% major complication rate. Pneumothorax represents the most frequent complication, but requires a chest tube drain in less than 10% of cases. Sustained complete tumour response has been reported in 85–90% of target lesions. Lesion size represents the most important risk factor for local recurrence. Survival data are still scarce, but initial results are very promising. In patients with stage I non-small-cell lung cancer, 1- and 2-year survival rates are within the ranges of 78–95% and 57–84%, respectively, with corresponding cancer-specific survival rates of 92% and 73%. In selected cases, the combination of RFA and radiotherapy could improve these results. In patients with colorectal lung metastasis, initial studies have reported survival data that compare favourably with the results of metastasectomy, with up to a 45% 5-year survival rate. Further studies are needed to understand the potential role of RFA as a palliative treatment in more advanced disease and the possible combination of RFA with other treatment options.Keywords
This publication has 47 references indexed in Scilit:
- Percutaneous Radiofrequency Ablation of Lung TumorsJournal of Thoracic Imaging, 2011
- Stereotactic Radiotherapy for Pulmonary Oligometastases: A Systematic ReviewJournal of Thoracic Oncology, 2010
- Lung Tumor Radiofrequency Ablation: Where Do We Stand?CardioVascular and Interventional Radiology, 2010
- Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastasesCancer, 2010
- Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patientsAnnals Of Oncology, 2010
- Radiofrequency and microwave ablation of lung tumorsJournal of Surgical Oncology, 2009
- Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot studyThe British Journal of Radiology, 2009
- Radiofrequency Ablation of Subpleural Lung Malignancy: Reduced Pain Using an Artificially Created PneumothoraxCardioVascular and Interventional Radiology, 2009
- Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)The Lancet Oncology, 2008
- Risk factors for local progression after percutaneous radiofrequency ablation of lung tumorsCancer, 2006